Please use this identifier to cite or link to this item:
Title: Diabetic ketoacidosis in acromegaly; a rare complication precipitated by corticosteroid use.
Austin Authors: Weiss, Jeremy ;Wood, Anna J;Zajac, Jeffrey D ;Grossmann, Mathis ;Andrikopoulos, Sofianos;Ekinci, Elif I 
Affiliation: Department of Endocrinology, Austin Health, Heidelberg Repatriation Hospital, Heidelberg West, Victoria, Australia
Department of Medicine, Austin Health and the University of Melbourne (Austin Campus), Parkville, VIC 3010, Australia
Issue Date: 2017 2017-12
Publication information: Diabetes research and clinical practice 2017; 134: 29-37
Abstract: Diabetic ketoacidosis has been described in the literature as a rare possible initial presentation of acromegaly before a diagnosis of acromegaly is eventually made. Indeed, diabetic ketoacidosis is a recognised complication of acromegaly. There are a number of factors that can predispose patients with acromegaly to diabetes as well as to diabetic ketoacidosis. These include high levels of growth hormone and insulin-like growth factor 1 in acromegaly and the effect on glycaemia by medications used in the management of acromegaly. Ketoacidosis has been described in patients with acromegaly even without the presence of an underlying autoimmune diabetes. Patients with acromegaly and ketoacidosis often respond to treatment and may not require long-term insulin.
DOI: 10.1016/j.diabres.2017.08.023
ORCID: 0000-0001-8261-3457
Journal: Diabetes research and clinical practice
PubMed URL: 28951345
Type: Journal Article
Subjects: Acromegaly
Somatostatin analogues
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.